Improving outcomes in the treatment of cancer
Location: United States, Massachusetts, Boston
Total raised: $60M
Investors 2
| Date | Name | Website |
| - | Adams Stre... | adamsstree... |
| - | Perceptive... | perceptive... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 01.02.2018 | Series A | $60M | - |
Mentions in press and media 10
| Date | Title | Description |
| 19.05.2021 | Partner Therapeutics Announces Publication of Clinical Trial Results of Leukine® (sargramostim) in Patients with Parkinson's Disease | |
| 24.03.2021 | Partner Therapeutics Announces Publication of Clinical Trial Results Showing Significant Benefit with Use of Leukine® (sargramostim) in Patients with Alzheimer's Disease | |
| 04.03.2021 | Partner Therapeutics Announces Partnership with SIRS Therapeutics and F4 Pharma to Explore Potential Uses for FX06 in Biodefense Applications | Partner Therapeutics, Inc. (PTx), announces a licensing and collaboration agreement with Munich-based SIRS Theraputics and Vienna-based F4 Pharma to support the development of FX-06, a synthetic peptide that has a broad spectrum of potentia... |
| 03.03.2021 | Partner Therapeutics Announces Partnership with SIRS Therapeutics and F4 Pharma to Explore Potential Uses for FX06 in Biodefense Applications | |
| 25.08.2020 | Partner Therapeutics Initiates Patient Enrollment in U.S. Clinical Trial Evaluating Leukine® (rhuGM-CSF, sargramostim) in COVID-19 Patients | |
| 01.04.2020 | Coronavirus Business Tracker: How The Private Sector Is Fighting The Covid-19 Pandemic | Alain Mérieux, founder of BioMérieux.AFP via Getty Images |
| 02.02.2018 | Term Sheet — Friday, February 2 | IPO DELAYS Good morning, Term Sheet readers. Paid Content You can't secure what you can't see From ExtraHop In an executive shakeup, Airbnb said its CFO, Laurence “L.T.” Tosi will be leaving the company and CEO Brian Chesky’s longtime deput... |
| 01.02.2018 | Partner Therapeutics Closes $60M Series A Financing | Partner Therapeutics, Inc. (PTx), a Boston, MA-based oncology company, closed a $60m Series A financing. Backers included Perceptive Advisors, Adams St. Partners and MidCap Financial. The company will use the funds to launch build a pipelin... |
| 01.02.2018 | Partner Therapeutics Closes $60 Million Financing | Partner Therapeutics, Inc. (PTx) announced today the closing of a Series A financing to support the launch and growth of the company. PTx is an oncology company focused on the development and commercialization of approved and late-stage the... |
| 01.02.2018 | Partner Therapeutics Pulls In $60M Series A | BOSTON, MA, Partner Therapeutics (PTx) announced today the closing of a Series A financing to support the launch and growth of the company. >> Click here for more funding data on Partner Therapeutics >> To export Partner The... |